These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25728154)

  • 41. Decreasing central-line-associated bloodstream infections in Connecticut intensive care units.
    Hong AL; Sawyer MD; Shore A; Winters BD; Masuga M; Lee H; Mathews SC; Weeks K; Goeschel CA; Berenholtz SM; Pronovost PJ; Lubomski LH;
    J Healthc Qual; 2013; 35(5):78-87. PubMed ID: 23347278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multitiered strategy of simulation training, kit consolidation, and electronic documentation is associated with a reduction in central line-associated bloodstream infections.
    Allen GB; Miller V; Nicholas C; Hess S; Cordes MK; Fortune JB; Blondin J; Ashikaga T; Ricci M
    Am J Infect Control; 2014 Jun; 42(6):643-8. PubMed ID: 24837115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beyond the intensive care unit bundle: Implementation of a successful hospital-wide initiative to reduce central line-associated bloodstream infections.
    Klintworth G; Stafford J; O'Connor M; Leong T; Hamley L; Watson K; Kennon J; Bass P; Cheng AC; Worth LJ
    Am J Infect Control; 2014 Jun; 42(6):685-7. PubMed ID: 24837122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nurse-driven quality improvement interventions to reduce hospital-acquired infection in the NICU.
    Ceballos K; Waterman K; Hulett T; Makic MB
    Adv Neonatal Care; 2013 Jun; 13(3):154-63; quiz 164-5. PubMed ID: 23722485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eliminating central line-associated bloodstream infections: a national patient safety imperative.
    Berenholtz SM; Lubomski LH; Weeks K; Goeschel CA; Marsteller JA; Pham JC; Sawyer MD; Thompson DA; Winters BD; Cosgrove SE; Yang T; Louis TA; Meyer Lucas B; George CT; Watson SR; Albert-Lesher MI; St Andre JR; Combes JR; Bohr D; Hines SC; Battles JB; Pronovost PJ;
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):56-62. PubMed ID: 24334799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained reduction of central line-associated bloodstream infections outside the intensive care unit with a multimodal intervention focusing on central line maintenance.
    Dumyati G; Concannon C; van Wijngaarden E; Love TM; Graman P; Pettis AM; Greene L; El-Daher N; Farnsworth D; Quinlan G; Karr G; Ward L; Knab R; Shelly M
    Am J Infect Control; 2014 Jul; 42(7):723-30. PubMed ID: 24856587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The incidence, aetiology and antimicrobial susceptibility of central line-associated bloodstream infections in intensive care unit patients at a private tertiary care hospital in Mumbai, India.
    Singhal T; Shah S; Thakkar P; Naik R
    Indian J Med Microbiol; 2019; 37(4):521-526. PubMed ID: 32436874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle.
    Guerin K; Wagner J; Rains K; Bessesen M
    Am J Infect Control; 2010 Aug; 38(6):430-3. PubMed ID: 20570395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*.
    Marsteller JA; Sexton JB; Hsu YJ; Hsiao CJ; Holzmueller CG; Pronovost PJ; Thompson DA
    Crit Care Med; 2012 Nov; 40(11):2933-9. PubMed ID: 22890251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of a multifaceted intervention on central line days in intensive care units: results of a national multisite study.
    Weeks KR; Hsu YJ; Yang T; Sawyer M; Marsteller JA
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S197-202. PubMed ID: 25239710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central and peripheral line-associated bloodstream infections in Australian neonatal and paediatric intensive care units: findings from a comprehensive Victorian surveillance network, 2008-2016.
    Worth LJ; Daley AJ; Spelman T; Bull AL; Brett JA; Richards MJ
    J Hosp Infect; 2018 May; 99(1):55-61. PubMed ID: 29222036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is zero central line-associated bloodstream infection rate sustainable? A 5-year perspective.
    Erdei C; McAvoy LL; Gupta M; Pereira S; McGowan EC
    Pediatrics; 2015 Jun; 135(6):e1485-93. PubMed ID: 25986020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of central venous catheter bundle in an intensive care unit in Kuwait: Effect on central line-associated bloodstream infections.
    Salama MF; Jamal W; Al Mousa H; Rotimi V
    J Infect Public Health; 2016; 9(1):34-41. PubMed ID: 26138518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is bloodstream infection preventable among premature infants? A tale of two cities.
    Aly H; Herson V; Duncan A; Herr J; Bender J; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1513-8. PubMed ID: 15930211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of a new multi-lumen infusion device to reduce central-venous-line-associated bloodstream infections in neonates.
    Martelin A; Picaud JC; Faton S; Pradat P; Pastor-Diez B; Haÿs S; Armoiry X
    J Hosp Infect; 2024 Oct; 152():114-121. PubMed ID: 39032568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multidisciplinary intervention to reduce central line-associated bloodstream infection in pediatrics and neonatal intensive care units.
    Hamza WS; Hamed EAM; Alfadhli MA; Ramadan MA
    Pediatr Neonatol; 2022 Jan; 63(1):71-77. PubMed ID: 34620576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era.
    Marra AR; Cal RG; Durão MS; Correa L; Guastelli LR; Moura DF; Edmond MB; Dos Santos OF
    Am J Infect Control; 2010 Aug; 38(6):434-9. PubMed ID: 20226570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A quality improvement initiative to reduce central line infection in neonates using checklists.
    Taylor JE; McDonald SJ; Earnest A; Buttery J; Fusinato B; Hovenden S; Wallace A; Tan K
    Eur J Pediatr; 2017 May; 176(5):639-646. PubMed ID: 28283785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
    Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
    Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dwell time and risk of central-line-associated bloodstream infection in neonates.
    Sanderson E; Yeo KT; Wang AY; Callander I; Bajuk B; Bolisetty S; Lui K;
    J Hosp Infect; 2017 Nov; 97(3):267-274. PubMed ID: 28651859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.